@schneiderleonid https://t.co/455SM3OHS5 Patient: 21211-101. 10/10
RT @PLMcCarthyMD: Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered TCells Induce Antitumor Activity in Solid Malignancies http…
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered TCells Induce Antitumor Activity in Solid Malignancies https://t.co/tN1PQ4qECx
In this article: https://t.co/tqd3SRKAOs @LFPancreaticCan is listed as giving a grant for this trial. But they had nothing to do w/THIS 4/
More Carl June Penn lies: His from all severe adverse effects, neurotoxicity & death during trial on day 97 in this: https://t.co/tqd3SRsZWU
More Carl June Penn lies: Taking advantage of HIPAA, they hid from you all that patient funded this: https://t.co/tqd3SRsZWU NOT A GRANT.
More Carl June Penn lies: https://t.co/tqd3SRsZWU Wasn't funded by Lustgarten b/c this: https://t.co/lrcbJBaWbl Announced AFTER trial over
Solid tumors: Failed to note Pt supplied $1M, severe AE's & death in trial -> boosted June's career/Novartis stock. https://t.co/bjAkcUitZX
Wait.... Didn't Carl June & Penn state that Pt received steroids & recovered in 24 hours? https://t.co/tqd3SRKAOs https://t.co/95mdRMvanU
Carl June & Penn: no Ascites withdrawal on "amended" day 92. Sure contradicts claims. https://t.co/tqd3SRKAOs https://t.co/sskGOuBIBa
Why was this article, claiming success with MesoCar in solid tumors from Carl June & Penn written at this time? https://t.co/tqd3SRKAOs
#Penn assured you their #MesoCar Pt had #pancreatic #cancer. Records don't lie, people do. http://t.co/Li6SGb5LAP http://t.co/WC4YdLkXOM
Personal/family pay in a Medicare Pt? A NOS dx code? Hint. http://t.co/Li6SGb5LAP #penn #pancreatic #Cartcells #meso http://t.co/aUim0o2rkq
Let's discuss million $ #bribe #carljune accepted for this "compassionate" case of (not) #pancreatic #cancer http://t.co/Li6SGb5LAP #penn
What's this? Failed 2 disclose kidney failure. #Penn #cancer #pancreatic #Mesothelin #car http://t.co/Li6SGb5LAP http://t.co/G7ljvXyK2E
#Penn #cancer forgot to disclose < 20 days after #MesoCar start Massive transudate ascites http://t.co/Li6SGb5LAP http://t.co/ftjJJ8OFkP
#penn assured you their Dec 2013 #MesoCar Pt had #pancreatic #cancer? http://t.co/Li6SGb5LAP More to come .... http://t.co/WvRfNJBERr
Amendment warning: #pancreatic #cancer #mesothelin #Penn #cartcells There was NO ASCITES WITHDRAWAL ON DAY 92 http://t.co/Li6SGbnmZp
Amendment warning: #pancreatic #cancer #mesothelin #Penn #cartcells There was NO ASCITES WITHDRAWAL ON DAY 92 http://t.co/Li6SGbnmZp
CAR-T MESO like FAP-CAR-T "produced potent antitumor effects in PREclinical xenografts" http://t.co/5LSriB7g8r $HALO Access $JUNO $NVS $KITE
#AACR15 Father Pt 21211-101 #Carljune accepted Million $ for preferential MesoCar #TCells Severe AE's, Death Day 97 http://t.co/bY6UPDmcg5
#AACR15 Pt 21211-101 Rapid development of profuse multi-liter Transudate Ascites, eventually bloody, then death. http://t.co/bY6UPDmcg5
@CancerResearch Father Pt 21211-101 gave #Carljune Million $ for preferential MesoCar. Severe AE's, Death on day 97. http://t.co/1lgEetKFXh
@CellTrials Father was Pt 21211-101 http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, Severe AE's & DEATH on day 97
@NatureRevCancer Father Pt 21211-101 http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, Severe AE's & DEATH on day 97
@Primary_Immune1 Father Pt 21211-101 http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, Severe AE's & DEATH on day 97
@stemcellnews Father was Pt 21211-101 http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, Severe AE's & DEATH on day 97
#AACR15 My father was Pt 21211-101 http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, Severe AE's & DEATH on day 97.
@heidiledford Father was Pt 21211-101 http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, Severe AE's & DEATH on day 97
@PanCAN My father was Pt 21211-101 http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, Severe AE's & DEATH on day 97.
@OfficialPCA Father Pt 21211-101 http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, Severe AE's & DEATH on day 97.
@PancreasCanceRR Father Pt 21211-101 http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, Severe AE's & DEATH on day 97.
@DeannaMc1 PS: Father Pt 21211-101. http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, severe AE's & DEATH on day 97.
@sciam Father Pt 21211-101. http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, severe AE's & DEATH on day 97.
@fezziwig2008 Father Pt 21211-101. http://t.co/1lgEetKFXh Failed to disclose NO Histological Pos Diagnosis, severe AE's & DEATH on day 97.
@natGeneTherapy Father Pt 21211-101. http://t.co/1lgEetKFXh Failed to mention NO Histological Pos Diagnosis, severe AE's & DEATH on day 97.
@CureCancerNow Father Pt 21211-101. http://t.co/1lgEetKFXh Failed to mention NO Histological Pos Diagnosis, severe AE's & DEATH on day 97.
@TheA2C Father PT 21211-101. Failed 2 mention no histological pos diagnosis, severe AE's & death on day 97. http://t.co/1lgEetKFXh
@Aiims1742 Father PT 21211-101. Failed 2 mention no histological pos diagnosis, severe AE's & death on day 97. http://t.co/1lgEetKFXh
@DorisDukeFdn Father PT 21211-101. Failed 2 mention no histological pos diagnosis, severe AE's & death on day 97. http://t.co/1lgEetKFXh
@DrEnologist It wasn't CRS. Weird infusion rxn. UPenn is looking at T-cells that express CART-meso only transiently. http://t.co/qw4B3ORcKf
Mesothelin-specific Chimeric Antigen Receptor mRNA-Engineered T cells Induce Anti-Tumor Activity in Solid Malignancie http://t.co/i0rqvkAYs5
#CancerImmunotherapy | mRNA-engineered CAR-based T cells for carcinoma & other solid tumors http://t.co/9br56IuPTX #paywall
#CancerImmunotherapy | mRNA-engineered CAR-based T cells for carcinoma & other solid tumors http://t.co/9br56IuPTX #paywall
My fav type of car: Mesothelin-specific Chimeric Antigen Receptors (#CAR) induce antitumor activity in solid tumors: http://t.co/hw12Qghlgi
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies http://t.co/Tzr2hhkMO3
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies http://t.co/Tzr2hhkMO3
Some very early results using CAR T cells to treat mesothelioma & pancreatic #cancer http://t.co/FDeiPPaM8H #immunotherapy